Innovative drug product development
Drug development services

Brevets inventés par des membres de l'INSCB

"Pharmaceutical composition having improved bioavailability" Breul T, Silvestro L. - WO 2012/156527 A1

CDIO_A_syllabus.pdf

"Enhanced bioavailability solid oral pharmaceutical containing a biphosphonic acid or one of the salts thereof" Breul T., Laruelle C. - WO 2011 / 080413A1

CDIO_A_syllabus.pdf

"Oral composition containing an antiplatelet agent of the thienopyridine family in the form of free base" Breul T., Laruelle C. - US 2011 / 0123606

CDIO_A_syllabus.pdf

"Method of dissolving essential oils in water" Breul T., Laruelle C., Taleb-Bendiab N. - WO 2009 / 019571 A2

CDIO_A_syllabus.pdf

"Pharmaceutical composition comprising a solid dispersion with a polymer matrix containing a continuous polydextrose phase and a continuous phase of a polymer other than polydextrose" Bedos M., Breul T., Byard S., Ribeiro Dos Santos I. - WO 2006 / 032762 A3

CDIO_A_syllabus.pdf

"Pharmaceuticalcomposition for oral administration of a pyrazole-3-carboxamide derivative" Breul T., Gautier J.C., Saslawski O.- WO 2005 / 046690 A1

CDIO_A_syllabus.pdf

"New stable injectable galenic form containing (2S)-2[4-[[(3S)-1-acetimidoyl-3-pyrrolidinyl]oxy]phenyl-3-(7-amidino-2-naphtyl) propanoic acid or one of the salts, hydrates and solvates thereof as a stable active ingredient" Breul T., Mafune Eiichi, Fujii Yoshimine - WO 00 / 64442

CDIO_A_syllabus.pdf

"Pharmaceutical dronedarone composition for parenteral administration" Bourriague-Seve, F., Breul, T. - WO 02 / 47660 A1

CDIO_A_syllabus.pdf

"A new parenteral composition of an anticoagulant" Breul, T. - FR 99 / 05345

CDIO_A_syllabus.pdf

"Pharmaceutical composition for injection based on a pharmaceutically acceptable clopidogrel or ticlopidin salt" Aleman, C., Breul, T. - WO 00/10534

CDIO_A_syllabus.pdf

"Pharmaceutical composition for oral administration of SR57746 chlorhydrate also comprising béta-cyclodextrin" Aleman, C., Bastard, P., Bonnel, M., Breul, T. - WO 99/33466

CDIO_A_syllabus.pdf

"Stable freeze-dried formulation consisting of an amorphous phase and a crystalline phase and including at least one non protein active principle" Bouloumie, C., Breul, T., Colliere, L., Faure, P. - WO 97/17064

CDIO_A_syllabus.pdf

"Stable liquid composition containing urate oxidase and lyophilized composition for its preparation" Aleman, C., Bayol, A., Breul, T., Dupin, P. - EP 0742013 A1

CDIO_A_syllabus.pdfCDIO_A_syllabus.pdf

"Stable freeze-dried formulation comprising a protein assay kit" Bayol, A., Breul, T., Dupin, P. Faure, P. - EP 0682944 A1

CDIO_A_syllabus.pdfCDIO_A_syllabus.pdf

"Triphasic emulsifiable fluid for use in cosmetics and pharmaceuticals comprises hydrophilic and lipophilic phases and intermediate phase of stable microemulsion" Breul, T. - FR89 / 15902

CDIO_A_syllabus.pdf